Company Snapshot

Investment Thesis

Baxter International provides medical devices, pharmaceuticals, and hospital products, with focus on renal care, medication delivery, and acute therapies. Portfolio reshaping and digital solutions target improved growth and margins.

  • Renal Leadership: Peritoneal dialysis and home therapies drive recurring revenue.
  • Hospital Products: Smart pumps, IV solutions, and nutrition support stickiness.
  • Portfolio Optimization: Spinoff of kidney care and divestitures streamline focus.

Strategic Mix

Medical Products Medication delivery, anesthesia
Kidney Care Peritoneal and hemodialysis
Pharma & Biopharma Solutions Injectables, contract manufacturing
Acute Therapies & Other Critical care devices

Mix approximates Baxter's core segments ahead of the renal spinoff.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Home Therapies

Shift toward home dialysis aligns with payer incentives.

Digital Pump Platform

Spectrum IQ adoption increases software/service revenue.

Balance Sheet Rebuild

Debt paydown and spinoff proceeds target deleveraging.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...